Veeva Systems Inc. (NYSE:VEEV – Get Free Report) gapped up prior to trading on Thursday after Morgan Stanley raised their price target on the stock from $195.00 to $201.00. The stock had previously closed at $219.94, but opened at $232.84. Morgan Stanley currently has an underweight rating on the stock. Veeva Systems shares last traded at $237.12, with a volume of 627,134 shares trading hands.
VEEV has been the topic of a number of other research reports. Stifel Nicolaus increased their price target on Veeva Systems from $240.00 to $272.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Robert W. Baird increased their target price on shares of Veeva Systems from $283.00 to $285.00 and gave the stock an “outperform” rating in a report on Thursday. Evercore ISI upped their price target on shares of Veeva Systems from $220.00 to $245.00 and gave the stock an “in-line” rating in a research report on Friday, December 6th. Needham & Company LLC reiterated a “buy” rating and set a $270.00 price objective on shares of Veeva Systems in a research note on Thursday. Finally, Wells Fargo & Company boosted their price objective on shares of Veeva Systems from $275.00 to $285.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $254.80.
View Our Latest Stock Analysis on VEEV
Institutional Investors Weigh In On Veeva Systems
Veeva Systems Price Performance
The stock has a market cap of $38.50 billion, a price-to-earnings ratio of 58.55, a PEG ratio of 1.89 and a beta of 0.85. The firm has a fifty day moving average of $223.82 and a 200 day moving average of $219.54.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Stories
- Five stocks we like better than Veeva Systems
- Energy and Oil Stocks Explained
- Taiwan Semi’s $100 Billion Investment: Fate of the Chipmakers
- Stock Analyst Ratings and Canadian Analyst Ratings
- 3 Stocks Primed for Compounding Wealth This Decade
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 2 Oversold Stocks With Major Reasons to Rebound
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.